Isophosphamide

DRUG3 trials

Sponsors

M.D. Anderson Cancer Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, The First Affiliated Hospital with Nanjing Medical University

Conditions

Diffuse Large B-cell LymphomaLymphomaOsteosarcoma

Phase 1

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Not yet recruitingNCT05590572

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityOsteosarcoma

Start: 2023-01-31End: 2027-12-31Target: 148Updated: 2022-10-21

Phase 2

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients

CompletedNCT00499343

M.D. Anderson Cancer CenterLymphoma

Start: 2004-01-31End: 2008-10-31Updated: 2013-08-02

Unknown Phase

R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

The First Affiliated Hospital with Nanjing Medical UniversityDiffuse Large B-cell Lymphoma

Start: 2023-04-15End: 2025-01-01Target: 60Updated: 2023-03-27

Related Papers

R-MINE-containing regimen in relapsed and refractory diffuse large B-cell lymphoma: a single-arm, multicenter phase II study

BMC Medicine2026-07-09

Novel Targeted Agents in Combination with R-MINE (RMINE+X) Based on Different Molecular Subtypes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma：a Phase 2 Multicenter Study

Blood2024-11-052 citations

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.

2010-04-142 citations